Clinical Report: Case Study of Follicular Dendritic Cell Sarcoma

Overview

This report presents a case of advanced follicular dendritic cell sarcoma (FDCS) in a 51-year-old woman, highlighting the diagnostic challenges and treatment strategies employed. The case underscores the importance of an integrative therapeutic approach involving immunotherapy and targeted therapy in managing this rare malignancy.

Background

Follicular dendritic cell sarcoma (FDCS) is a rare malignant neoplasm that poses significant diagnostic and therapeutic challenges due to its aggressive nature and potential for metastasis. Understanding FDCS is crucial for healthcare professionals as it requires a tailored approach to treatment, often involving a combination of chemotherapy and immunotherapy. The rarity of this condition necessitates ongoing research and case studies to improve management strategies.

Data Highlights

No numerical data available in the article.

Key Findings

• The patient presented with advanced FDCS arising in the mediastinum with multiple metastases.
• Initial diagnostic imaging suggested malignancy, leading to a complex diagnostic workup.
• Histopathological analysis confirmed the diagnosis of FDCS with metastatic involvement.
• The treatment regimen included gemcitabine, docetaxel, and a PD-1 monoclonal antibody.
• Follow-up imaging indicated a slight reduction in the size of the mediastinal mass after treatment.

Clinical Implications

This case highlights the need for a multidisciplinary approach in diagnosing and treating FDCS, emphasizing the role of advanced imaging and histopathological evaluation. Clinicians should consider integrating immunotherapy with traditional chemotherapy for improved patient outcomes in advanced FDCS cases.

Conclusion

The management of follicular dendritic cell sarcoma requires a comprehensive understanding of its clinical behavior and an adaptable treatment strategy. Continued research and case documentation are essential for enhancing therapeutic approaches for this rare malignancy.

Related Resources & Content

1. Frontiers in Oncology, 2026 -- Case Report: Lenalidomide as a novel maintenance therapy for metastatic follicular dendritic cell sarcoma
2. Frontiers in Immunology, 2026 -- Follicular dendritic cell sarcoma associated with IgG4-related disease: a case report and literature review
3. Blood Cancer Journal, 2025 -- Concurrent Presence of Clonally Related Follicular Lymphoma and Histiocytic Sarcoma
4. Blood Cancer Journal, 2023 -- Association of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm with Myelodysplastic Syndrome Arising from Clonal Hematopoiesis
5. Primary hepatic follicular dendritic cell sarcoma: A case study and literature review - PMC
6. Follicular dendritic cell sarcoma - PMC
7. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report - PMC
8. Primary hepatic follicular dendritic cell sarcoma: A case study and literature review - PMC
9. Follicular dendritic cell sarcoma - PMC
10. Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report - PMC